Pricing Log in Create free account

Senesco Technologies Inc. (ELOX) vs Xilio Therapeutics, Inc. (XLO)

Senesco Technologies Inc. and Xilio Therapeutics, Inc. are both Biotechnology companies. Senesco Technologies Inc. and Xilio Therapeutics, Inc. are of similar size ($59.4M and $55.3M). Senesco Technologies Inc. has the higher net margin (0.00% vs −34.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Senesco Technologies Inc. leads on 6 and Xilio Therapeutics, Inc. on 5.

Valuation

Metric ELOX XLO Biotechnology median
P/E n/m n/m 8.50
P/S n/m 2.66 9.71
P/B 1.91 2.36 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 0.56 9.21
Earnings yield (91.56%) (17.00%) (33.15%)
Free cash flow yield (11.79%) (36.00%) (25.50%)

Profitability

Metric ELOX XLO Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (48.94%) 0.00%
Net margin 0.00% (34.06%) 0.00%
Free cash flow margin 0.00% (95.59%) 0.00%
Return on equity (89.91%) (55.03%) (56.36%)
Return on assets (34.15%) (15.16%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ELOX XLO Biotechnology median
Revenue growth (TTM) — 327.25% 6.02%
EPS growth (last fiscal year) 41.93% 72.55% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELOX XLO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.74 4.25 4.72
Net debt to EBITDA 0.61 3.40 0.96

Dividend

Metric ELOX XLO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ELOX XLO Biotechnology median
Market cap 55.30m 59.35m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack